Clindamycin HCl recalled over manufacturing violations
- Recall date
- March 24, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- RemedyRepack Inc. recalls Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15…
- Recall number
- D-0378-2025
- FDA classification
- Class II
- Brand / firm
- RemedyRepack Inc.
- Sold / distributed
- PA
Why it was recalled
CGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00
Get recall alerts
Free email alert whenever RemedyRepack Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RemedyRepack Inc.